Scleroderma, Myositis and Related Syndromes 2018
DOI: 10.1136/annrheumdis-2018-eular.6811
|View full text |Cite
|
Sign up to set email alerts
|

AB0729 Quality of life assessment in systemic sclerosispatients treated with autologous stem cell transplantation: a longitudinal study

Abstract: BackgroundAutologous Hematopoietic Stem Cell Transplantation (AHSCT) has been explored as a therapeutic option for patients with systemic sclerosis (SSc) that do not respond to conventional treatment.ObjectivesTo investigate changes in quality of life of severe and rapidly progressive SSc patients treated with AHSCT.MethodsThis is a longitudinal and comparative study. Patients were evaluated before (n=27), and at 6 (n=27) and 12 months (n=21) after AHSCT. The Generic Questionnaire for Evaluation of Quality of … Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles